Rituximab - induced remission of nephropatic syndrome in patients with membranous nephropathy.Commentary on:CJASM 4,2009,1083-88

Abstract

Rituximab, nephrotic syndrome, patients with membrabous nephropathy, progression, terminal renal failure, risk of chronic nefrotoxicity, relaps

Keywords

• Rituximab
• nephrotic syndrome
• patients with membrabous nephropathy
• progression terminal renal failure